Literature DB >> 10601632

LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions.

T J Resink1, Y S Kuzmenko, F Kern, D Stambolsky, V N Bochkov, V A Tkachuk, P Erne, T Niermann.   

Abstract

T-cadherin (T-cad) is an unusual glycosylphosphatidylinositol-anchored member of the cadherin family of cell adhesion molecules. Binding of low density lipoproteins (LDLs) to T-cad can be demonstrated on Western blots of smooth muscle cell lysates, membranes and purified proteins. Using HEK293 cells transfected with human T-cad cDNA (T-cad+), we have investigated the adhesion properties of expressed mature and precursor proteins and examined the postulate that LDL represents a physiologically relevant ligand for T-cad. T-cad+ exhibits an increased Ca(2+)-dependent aggregation (vs. control) that was reduced by selective proteolytic cleavage of precursor T-cad and abolished after either proteolytic or phosphatidylinositol-specific phospholipase C (PI-PLC) cleavage of both mature and precursor proteins, indicating that both proteins function in intercellular adhesion. T-cad+ exhibited a significantly increased specific cell surface-binding of [(125)I]-LDL that was sensitive to PI-PLC pre-treatment of cells. Ca(2+)-dependent intercellular adhesion of T-cad+ was significantly inhibited by LDL. Our results support the suggestion that LDL is a physiologically relevant ligand for T-cad.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601632     DOI: 10.1016/s0014-5793(99)01594-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  LDL induces intracellular signalling and cell migration via atypical LDL-binding protein T-cadherin.

Authors:  K Rubina; E Talovskaya; V Cherenkov; D Ivanov; D Stambolsky; T Storozhevykh; V Pinelis; A Shevelev; Ye Parfyonova; T Resink; P Erne; V Tkachuk
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

2.  Identification of proteins associating with glycosylphosphatidylinositol- anchored T-cadherin on the surface of vascular endothelial cells: role for Grp78/BiP in T-cadherin-dependent cell survival.

Authors:  Maria Philippova; Danila Ivanov; Manjunath B Joshi; Emmanouil Kyriakakis; Katharina Rupp; Taras Afonyushkin; Valery Bochkov; Paul Erne; Therese J Resink
Journal:  Mol Cell Biol       Date:  2008-04-14       Impact factor: 4.272

3.  T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression.

Authors:  Zhi-yong Huang; YanLi Wu; Nicolé Hedrick; David H Gutmann
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

4.  A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes.

Authors:  Chia-Min Chung; Tsung-Hsien Lin; Jaw-Wen Chen; Hsin-Bang Leu; Hsin-Chou Yang; Hung-Yun Ho; Chih-Tai Ting; Sheng-Hsiung Sheu; Wei-Chuan Tsai; Jyh-Hong Chen; Shing-Jong Lin; Yuan-Tsong Chen; Wen-Harn Pan
Journal:  Diabetes       Date:  2011-07-19       Impact factor: 9.461

5.  Role of the adiponectin binding protein, T-cadherin (cdh13), in pulmonary responses to subacute ozone.

Authors:  David I Kasahara; Alison S Williams; Leandro A Benedito; Barbara Ranscht; Lester Kobzik; Christopher Hug; Stephanie A Shore
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

6.  Functional properties of rare missense variants of human CDH13 found in adult attention deficit/hyperactivity disorder (ADHD) patients.

Authors:  Thegna Mavroconstanti; Stefan Johansson; Ingeborg Winge; Per M Knappskog; Jan Haavik
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

7.  Plasma proteomic profiling of young and old mice reveals cadherin-13 prevents age-related bone loss.

Authors:  Yong Ryoul Yang; Mohammad Humayun Kabir; Jin Hee Park; Jae-Il Park; Jae Sook Kang; Shinyeong Ju; Yeo Jin Shin; Seung Min Lee; Jaemin Lee; Seokho Kim; Kwang-Pyo Lee; Soo Young Lee; Cheolju Lee; Ki-Sun Kwon
Journal:  Aging (Albany NY)       Date:  2020-05-12       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.